Tacrolimus induced hepatotoxicity in a patient with bilateral lung transplant

Transplant International

Volumn 25, Issue 10, 2012, Pages

  Sacher, Vikas Y ^a   Bejarano, Pablo A ^a   Pham, Si M ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CYCLOSPORIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); MEPREDNISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; TACROLIMUS;

ADULT; CASE REPORT; CHRONIC RESPIRATORY FAILURE; CHRONIC SINUSITIS; CYSTIC FIBROSIS; DIABETES MELLITUS; HEART TAMPONADE; HEPATITIS C; HUMAN; KIDNEY FAILURE; LETTER; LIVER BIOPSY; LIVER CELL; LIVER FAILURE; LIVER FUNCTION TEST; LIVER TOXICITY; LUNG TRANSPLANTATION; MALE; NEPHROTOXICITY; NEUROTOXICITY; PANCREAS INSUFFICIENCY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT DURATION;

ADULT; BILIRUBIN; CYSTIC FIBROSIS; HEPATITIS C; HEPATOCYTES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER DISEASES; LUNG TRANSPLANTATION; MALE; RESPIRATORY INSUFFICIENCY; TACROLIMUS;

EID: 84866291764     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01546.x     Document Type: Letter

References (10)

1. Ganschow R, Albani J, Grabhorn E, Richter A, Burdelski M,. Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection. Pediatr Transplant 2006; 10: 220.
2. Corbani A, Burroughs AK,. Intrahepatic cholestasis after liver transplantation. Clin Liver Dis 2008; 12: 111.
3. Taniai N, Akimaru K, Ishikawa Y, et al. Hepatotoxicity caused by both tacrolimus and cyclosporine after living donor liver transplantation. J Nippon Med Sch 2008; 75: 187.
4. Oto T, Okazaki M, Takata K, et al. Calcineurin inhibitor-related cholestasis complicating lung transplantation. Ann Thorac Surg 2010; 89: 1664.
5. Fong TL, Cho YW, Hou L, Hutchinson IV, Barbers RG, Herrington CS,. Outcomes after lung transplantation and practices of lung transplant programs in the United States regarding hepatitis C seropositive recipients. Transplantation 2011; 91: 1293.
6. Fabrizi F, Bromberg J, Elli A, Dixit V, Martin P,. Review article: hepatitis C virus and calcineurin inhibition after renal transplantation. Aliment Pharmacol Ther 2005; 22: 657.
7. Brunt EM, Di Bisceglie AM,. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis. Hum Pathol 2004; 35: 509.
8. Wisell J, Boitnott J, Haas M, et al. Glycogen pseudoground glass change in hepatocytes. Am J Surg Pathol 2006; 30: 1085.
9. Bejarano PA, Garcia MT, Rodriguez MM, Ruiz P, Tzakis AG,. Liver glycogen bodies: ground-glass hepatocytes in transplanted patients. Virchows Arch 2006; 449: 539.
10. Lefkowitch JH, Lobritto SJ, Brown Jr RS, et al. Ground-glass, polyglucosan like hepatocellular inclusions: a 'new' diagnostic entity. Gastroenterology 2006; 131: 713.